Buccal, polar and non-polar sprays containing propofol
Buccal aerosol sprays using polar and/or non-polar solvents have now been developed which provide propofol for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: propofol, a polar solvent and an optional flavoring agent; formulation II: propofol, a polar solvent, a propellant, and an optionally flavoring agent; formulation III: propofol, a non-polar solvent, and an optional flavoring agent; formulation IV: propofol, a non-polar solvent, a propellant, and an optional flavoring agent; formulation V: propofol, a mixture of a polar solvent and a non-polar solvent, and an optional flavoring agent; and formulation VI: propofol, a mixture of a polar solvent and a non-polar solvent, a propellant, and an optional flavoring agent.
1 - 18 . (canceled)
19 . An oral spray composition for transmucosal administration of propofol comprising:
propofol in an amount of between about 1 and about 85 percent by weight of the total composition;
a polar solvent in an amount between about 1 and about 85 percent by weight of the total composition; and
a propellant in an amount between about 10 and about 90 percent by weight of the total composition, wherein said propellant comprises a C 3 to C 8 hydrocarbon of linear or branched configuration.
20 . The composition of claim 19 , further comprising a taste mask and/or flavoring agent in an amount between about 0.01 and about 5 percent by weight of the total composition.
21 . The composition of claim 20 , wherein the propofol is present in an amount between about 5 and 75 percent by weight of the total composition, the polar solvent is present in an amount between about 5 and about 75 percent by weight of the total composition, the propellant is present in an amount between about 10 and about 85 percent by weight of the composition, and the taste mask and/or flavoring agent is present in an amount between about 0.5 and about 4 percent by weight of the total composition.
22 . The composition of claim 21 , wherein the propofol is present in an amount between about 10 and about 70 percent by weight of the total composition, the polar solvent is present in an amount between about 10 and about 60 percent by weight of the total composition, the propellant is present in an amount between about 15 and about 65 percent by weight of the composition, and taste mask and/or flavoring agent is present in an amount between about 1 and about 2 percent by weight of the total composition.
23 . The composition of claim 19 , wherein the solvent comprises a polyethylene glycol having a molecular weight between 400 and 1000, C 2 to C 8 mono- and poly-alcohol, or C 7 to C 18 alcohol of linear or branched configuration.
24 . The composition of claim 23 , wherein the solvent comprises polyethylene glycol.
25 . The composition of claim 23 , wherein the solvent comprises ethanol.
26 . The composition of claim 20 , wherein the flavoring agent comprises a synthetic or natural oil of peppermint, oil of spearmint, citrus oil, fruit flavor, sweetener, or mixture thereof.
27 . The composition of claim 19 , wherein the propellant comprises propane, N-butane, iso-butane, N-pentane, iso-pentane, neo-pentane, or mixture thereof.
28 . The composition of claim 19 , further comprising an absorption enhancer in an amount of between about 0.01 to about 5 percent by weight of the total composition.
29 . The composition of claim 21 , further comprising an absorption enhancer in an amount of between about 0.5 to about 4 percent by weight of the total composition.
30 . The composition of claim 22 , further comprising an absorption enhancer in an amount of between about 1 to about 2 percent by weight of the total composition.
31 . The composition of claim 28 , wherein the absorption enhancer comprises oleic acid, 23-lauryl ether, aprotinin, azone, benzalkonium chloride, cetylpyridinium chloride, cetyltrimethylammonium bromide, cyclodextrin, dextran sulfate, lauric acid, lauric acid/propylene glycol, lysophosphatidylcholine, menthol, methoxysalicylate, methyloleate, phosphatidylcholine, polyoxyethylene, polysorbate 80, sodium EDTA (ethylenediamine tetraacetic acid), sodium glycocholate, sodium glycodeoxycholate, sodium lauryl sulfate, sodium salicylate, sodium taurocholate, sodium taurodexycholate, sulfoxides or an alkyl glycoside.
32 . The composition of claim 19 , further comprising an antioxidant in an amount of between about 0.01 to about 20 percent by weight of the total composition.
33 . The composition of claim 21 , further comprising an antioxidant in an amount of between about 0.5 to about 10 percent by weight of the total composition.
34 . The composition of claim 22 , further comprising an antioxidant in an amount of between about 1 to about 2 percent by weight of the total composition.
35 . The composition of claim 32 , wherein the antioxidant comprises ascorbyl palmitate, alpha tocopherol, butylated hydroxyanisole or fumaric acid.
36 . A method of administering propofol to a mammal, comprising spraying the oral mucosa of the mammal with the composition of claim 19 .
37 . The method of claim 36 , wherein the amount of the spray is predetermined.
38 - 54 . (canceled)
55 . An oral spray composition for transmucosal administration of propofol comprising:
propofol in an amount between about 1 and about 85 percent by weight of the total composition; and
a non-polar solvent in an amount between about 1 and about 85 percent by weight of the total composition; and
a propellant in an amount between about 10 and about 90 percent by weight of the total composition, wherein said propellant comprises a C 3 to C 8 hydrocarbon of linear or branched configuration.
56 . The composition of claim 55 further comprising a taste mask and/or flavoring agent in an amount of between about 0.01 and about 5 percent by weight of the total composition.
57 . The buccal spray composition of claim 56 , wherein the propofol is present in an amount between about 5 and about 75 percent by weight of the total composition; the non-polar solvent is present in an amount between about 5 and about 75 percent by weight of the total composition; the propellant is present in an amount between about 10 to about 85 percent by weight of the total composition; and the taste mask and/or flavoring agent is present in an amount between about 0.5 to about 4 percent by weight of the total composition.
58 . The buccal spray composition of claim 57 , wherein the propofol is present in an amount between about 10 and about 70 percent by weight of the total composition; the non-polar solvent is present in an amount between about 10 and about 60 percent by weight of the total composition; the propellant is present in an amount between about 15 to about 65 percent by weight of the total composition; and the taste mask and/or flavoring agent is present in an amount between about 1 to about 2 percent by weight of the total composition.
59 . The composition of claim 55 , wherein the solvent comprises a (C 2 -C 24 ) fatty acid (C 2 -C 6 ) ester, C 7 -C 18 hydrocarbon of linear or branched configuration, C 2 -C 6 alkanoyl ester, or triglyceride of C 2 -C 6 carboxylic acids.
60 . The composition of claim 59 , wherein the solvent comprises a triglyceride of C 2 -C 6 carboxylic acids.
61 . The composition of claim 56 , wherein the flavoring agent comprises a synthetic or natural oil of peppermint, oil of spearmint, citrus oil, fruit flavor, sweetener, or mixture thereof.
62 . The composition of claim 55 , wherein the propellant comprises propane, n-butane, iso-butane, n-pentane, iso-pentane, neo-pentane, or mixture thereof.
63 . The composition of claim 62 , wherein the propellant comprises n-butane or iso-butane having a water content of not more than 0.2 percent and a concentration of oxidizing agents, reducing agents, Lewis acids, and Lewis bases of less than 0.1 percent.
64 . The composition of claim 55 , further comprising an absorption enhancer in an amount of between about 0.01 to about 5 percent by weight of the total composition.
65 . The composition of claim 57 , further comprising an absorption enhancer in an amount of between about 0.5 to about 4 percent by weight of the total composition.
66 . The composition of claim 58 , further comprising an absorption enhancer in an amount of between about 1 to about 2 percent by weight of the total composition.
67 . The composition of claim 64 , wherein the absorption enhancer comprises oleic acid, 23-lauryl ether, aprotinin, azone, benzalkonium chloride, cetylpyridinium chloride, cetyltrimethylammonium bromide, cyclodextrin, dextran sulfate, lauric acid, lauric acid/propylene glycol, lysophosphatidylcholine, menthol, methoxysalicylate, methyloleate, phosphatidylcholine, polyoxyethylene, polysorbate 80, sodium EDTA (ethylenediamine tetraacetic acid), sodium glycocholate, sodium glycodeoxycholate, sodium lauryl sulfate, sodium salicylate, sodium taurocholate, sodium taurodeoxycholate, sulfoxides or an alkyl glycoside.
68 . The composition of claim 55 , further comprising an antioxidant in an amount of between about 0.01 to about 20 percent by weight of the total composition.
69 . The composition of claim 57 , further comprising an antioxidant in an amount of between about 0.5 to about 10 percent by weight of the total composition.
70 . The composition of claim 58 , further comprising an antioxidant in an amount of between about 1 to about 2 percent by weight of the total composition.
71 . The composition of claim 68 , wherein the antioxidant comprises ascorbyl palmitate, alpha tocopherol, butylated hydroxyanisole or fumaric acid.
72 . A method of administering propofol to a mammal, comprising spraying the oral mucosa of the mammal with the composition of claim 55 .
73 - 90 . (canceled)
91 . An oral spray composition for transmucosal administration of propofol comprising:
propofol in an amount between about 1 and about 80 percent by weight of the total composition;
a polar solvent in an amount of between about 2 to about 80 percent by weight of the total composition; and
a non-polar solvent in an amount of between about 1 to about 80 percent by weight of the total composition; and
a propellant in an amount between about 10 to about 90 percent by weight of the total composition, wherein said propellant comprises a C 3 to C 8 hydrocarbon of linear or branched configuration.
92 . The composition of claim 91 , wherein the ratio of the polar solvent to the non-polar solvent ranges from about 1:99 to about 99:1.
93 . The composition of claim 91 , further comprising a taste mask and/or flavoring agent is present in an amount between about 0.01 and about 5 percent by weight of the total composition.
94 . The composition of claim 93 , wherein the propofol is present in an amount from between about 5 to about 75 percent by weight of the total composition, the polar solvent is present in an amount between about 5 to about 75 percent by weight of the total composition, the non-polar solvent is present in an amount between about 2 to about 75 percent by weight of the total composition, the propellant is present in an amount between about 10 to about 85 percent by weight of the total composition, and the taste mask and/or flavoring agent is present in an amount between about 0.5 and about 4 percent by weight of the total composition.
95 . The composition of claim 94 , wherein the propofol is present in an amount from between about 10 to about 60 percent by weight of the total composition, the polar solvent is present in an amount between about 10 to about 60 percent by weight of the total composition, the non-polar solvent is present in an amount between about 10 to about 60 percent by weight of the total composition, the propellant is present in an amount between about 15 to about 65 percent by weight of the total composition, and the taste mask and/or flavoring agent is present in an amount between about 1 and about 2 percent by weight of the total composition.
96 . The composition of claim 91 , wherein the polar solvent comprises a polyethylene glycol having a molecular weight between 400 and 1000, C 2 to C 8 mono- and poly-alcohol, or C 7 to C 18 alcohol of linear or branched configuration and the non-polar solvent comprises a (C 2 -C 24 ) fatty acid (C 2 -C 6 ) ester, C 7 -C 18 hydrocarbon of linear or branched configuration, C 2 -C 6 alkanoyl ester, or triglyceride of C 2 -C 6 carboxylic acids.
97 . The composition of claim 93 , wherein the flavoring agent comprises a synthetic or natural oil of peppermint, oil of spearmint, citrus oil, fruit flavor, sweetener, or mixture thereof.
98 . The composition of claim 91 , wherein the propellant comprises propane, n-butane, iso-butane, n-pentane, iso-pentane, neo-pentane, or a mixture thereof.
99 . The composition of claim 98 , wherein the propellant comprises n-butane or iso-butane having a water content of not more than 0.2 percent and a concentration of oxidizing agents, reducing agents, Lewis acids, and Lewis bases of less than 0.1 percent.
100 . The composition of claim 91 , further comprising an absorption enhancer in an amount of between about 0.01 to about 5 percent by weight of the total composition.
101 . The composition of claim 94 , further comprising an absorption enhancer in an amount of between about 0.5 to about 4 percent by weight of the total composition.
102 . The composition of claim 95 , further comprising an absorption enhancer in an amount of between about 1 to about 2 percent by weight of the total composition.
103 . The composition of claim 100 , wherein the absorption enhancer comprises oleic acid, 23-lauryl ether, aprotinin, azone, benzalkonium chloride, cetylpyridinium chloride, cetyltrimethylammonium bromide, cyclodextrin, dextran sulfate, lauric acid, lauric acid/propylene glycol, lysophosphatidylcholine, menthol, methoxysalicylate, methyloleate, phosphatidylcholine, polyoxyethylene, polysorbate 80, sodium ESTA (ethylenediamine tetraacetic acid), sodium glycocholate, sodium glycodeoxycholate, sodium lauryl sulfate, sodium salicylate, sodium taurocholate, sodium taurodeoxycholate, sulfoxides or an alkyl glycoside.
104 . The composition of claim 91 , further comprising an antioxidant in an amount of between about 0.01 to about 20 percent by weight of the total composition.
105 . The composition of claim 94 , further comprising an antioxidant in an amount of between about 0.5 to about 10 percent by weight of the total composition.
106 . The composition of claim 95 , further comprising an antioxidant in an amount of between about 1 to about 2 percent by weight of the total composition.
107 . The composition of claim 104 , wherein the antioxidant comprises ascorbyl palmitate, alpha tocopherol, butylated hydroxyanisole or fumaric acid.
108 . A method of administering propofol to a mammal, comprising spraying the oral mucosa of the mammal with the composition of claim 91 .
109 . The method of claim 108 , wherein the amount of the spray is predetermined.